本頁面由Tiger Trade Technology Pte. Ltd.提供服務

PMV Pharmaceuticals

1.40
-0.0400-2.78%
盤後1.430.0300+2.14%19:31 EDT
成交量:53.87萬
成交額:78.73萬
市值:1.06億
市盈率:-0.99
高:1.51
開:1.45
低:1.40
收:1.44
52周最高:1.88
52周最低:1.02
股本:7,551.31萬
流通股本:6,838.37萬
量比:0.80
換手率:0.79%
股息:- -
股息率:- -
每股收益(TTM):-1.4131
每股收益(LYR):-1.4800
淨資產收益率:-70.93%
總資產收益率:-42.39%
市淨率:1.48
市盈率(LYR):-0.95

資料載入中...

2026/09/02

重要事件披露

Form 8-K - Current report
2026/09/01

重要事件披露

Form 8-K - Current report
2026/08/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/14

重要事件披露

Form 8-K - Current report
2026/07/29

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/10

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/06/05

重要事件披露

Form 8-K - Current report
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/12

重要事件披露

Form 8-K - Current report
2026/05/12

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/05

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/03/06

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/06

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/03/06

重要事件披露

Form 8-K - Current report
2025/11/12

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/12

重要事件披露

Form 8-K - Current report
2025/10/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/09/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/09/10

重要事件披露

Form 8-K - Current report
2025/08/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]